Neuropathy in Smoldering Myeloma: More Common Than Expected | IMS 2026 #myeloma

Eileen Kurre, a project manager at University Hospital Heidelberg, discusses peripheral neuropathy symptoms and quality of life in smoldering myeloma at IMS 2026 in Glasgow. In a study of 127 patients, 84% reported mild or moderate neuropathy symptoms, women reported more symptoms than men, and quality of life was lower than in the general population. She discusses what is still unknown and why these findings raise questions about describing smoldering myeloma as symptom-free.

If this video has helped you or a loved one, consider donating to HealthTree. Every donation helps us continue to create free and high-quality blood cancer educational content: https://give.healthtree.org/give/628617/src=htu

For an organized lesson structure, watch on our site here: https://linktr.ee/HealthTreeUniversity
Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer!

Patients have the key to find cures for cancer. Learn more about HealthTree's services here: https://healthtree.org/curehub?utm_source=social+media&utm_medium=htu+youtube&utm_campaign=htu-curehub&utm_content=general
Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.

Timestamps:
0:00 Introduction
0:19 Why study neuropathy in smoldering myeloma?
0:58 Results: 84% reported symptoms
1:53 Differences by sex and disease factors
2:22 Next steps: a multicenter study
2:59 Rethinking "asymptomatic" smoldering myeloma